Matthew Hardwick, PhD
Mary Beth Minyard, MSCLS, M(ASCP)
Mary Beth Minyard, MSCLS, M(ASCP) is Co-Founder and Chief Science Officer of ResInnova Clinical Diagnostics. A board-certified Microbiologist with over 20 years of experience in clinical and applied infectious disease testing, Mary Beth also serves as Principal Consultant to multiple clinical labs and biotech companies and serves on the CLSI Document Development Committee for establishing molecular testing in clinical environments. She has served as Director of Laboratory Operations and Technical Supervisor for a molecular diagnostics laboratory which became one the of the first private labs in the U.S. to provide SARS-CoV-2 (COVID-19) testing. She went on to start COVID-19 programs for both environmental surface testing and pooled surveillance and recently published on the predictors of non-seroconversion after SARS-CoV-2 infection. Mary Beth earned her Bachelor of Science in Microbiology from the University of Georgia and her Master of Science in Clinical Laboratory Sciences from the University of Alabama at Birmingham (UAB) specializing in Microbiology and Immunology.